Showing results (2811-2820 of 3,090) with videos related to
Sort By:
Pageof 309
Drug Safety|January 3, 2019
MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical NotesXi Yang, Jiang Bian, Yan Gong, et al.Drug Safety|November 3, 2019
Exposure to Infliximab During Pregnancy: Post-Marketing ExperienceAnja Geldhof, Jennifer Slater, Michael Clark, et al.Drug Safety|April 25, 2009
Bias in benefit-risk appraisal in older products: the case of buflomedil for intermittent claudicationTine L M De Backer, Robert H Vander Stichele, Luc M Van BortelDrug Safety|February 25, 2009
Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitionsManfred Hauben, Jeffrey K AronsonDrug Safety|February 25, 2009
Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting SystemAlan M Hochberg, Ronald K Pearson, Donald J O'Hara, et al.Drug Safety|April 3, 2009
First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in ItalyMarco De Santis, Elena Di Gianantonio, Elena Cesari, et al.Drug Safety|October 9, 2008
Detection of adverse drug events and other treatment outcomes using an electronic prescribing systemTewodros Eguale, Robyn Tamblyn, Nancy Winslade, et al.Drug Safety|August 13, 2009
Benefit-risk assessment of sunitinib in gastrointestinal stromal tumours and renal cancerNathalie Theou-Anton, Sandrine Faivre, Chantal Dreyer, et al.Drug Safety|August 13, 2009
Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessmentRobert A Byrne, Nikolaus Sarafoff, Adnan Kastrati, et al.Drug Safety|August 29, 2007
Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthmaPaul B Watkins, Louise M Dube, Karen Walton-Bowen, et al.Pageof 309